These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20204363)

  • 1. Spontaneous bilateral pneumothorax in metastatic renal cell carcinoma on sunitinib therapy.
    Katta A; Fesler MJ; Tan A; Vuong G; Richart JM
    Cancer Chemother Pharmacol; 2010 Jul; 66(2):409-12. PubMed ID: 20204363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Successful sunitinib treatment of metastatic renal cell carcinoma in a patient with end stage renal disease on hemodialysis.
    Park CY
    Anticancer Drugs; 2009 Oct; 20(9):848-9. PubMed ID: 19644356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance of sunitinib in dialyzed patients with metastatic renal cell carcinoma.
    Vickers MM; Heng DY; Hemmelgarn B; Eigl BJ
    Clin Genitourin Cancer; 2009 Oct; 7(3):E104-6. PubMed ID: 19815480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sunitinib (Sutent): a novel agent for the treatment of metastatic renal cell carcinoma.
    Chouhan JD; Zamarripa DE; Lai PH; Oramasionwu CU; Grabinski JL
    J Oncol Pharm Pract; 2007 Mar; 13(1):5-15. PubMed ID: 17621562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyperlipidemia and hypothyroidism among metastatic renal cell carcinoma patients taking sunitinib malate. Related or unrelated adverse events?
    Tassi R; Baldazzi V; Lapini A; Carini M; Mazzanti R
    Clin Genitourin Cancer; 2015 Apr; 13(2):e101-5. PubMed ID: 25450040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of hemodialyzed patients with sunitinib in renal cell carcinoma.
    Park S; Lee J; Park SH; Park JO; Kang WK; Park YS; Cho JH; Lim HY
    Chemotherapy; 2010; 56(6):485-91. PubMed ID: 21099221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Response to sorafenib after sunitinib-induced acute heart failure in a patient with metastatic renal cell carcinoma: case report and review of the literature.
    Wong MK; Jarkowski A
    Pharmacotherapy; 2009 Apr; 29(4):473-8. PubMed ID: 19323623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of psoriasis during sunitinib therapy for renal cell carcinoma.
    Narayanan S; Callis-Duffin K; Batten J; Agarwal N
    Am J Med Sci; 2010 Jun; 339(6):580-1. PubMed ID: 20421784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary artery thrombosis mimicking disease progression in metastatic renal cell carcinoma on Sunitinib.
    Ahmad M; Prasad S; Krishna MV; Lavingia V
    Indian J Cancer; 2016; 53(1):112-3. PubMed ID: 27146756
    [No Abstract]   [Full Text] [Related]  

  • 10. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma and various other solid tumors.
    Polyzos A
    J Steroid Biochem Mol Biol; 2008 Feb; 108(3-5):261-6. PubMed ID: 17945482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe neurological symptoms in a patient with advanced renal cell carcinoma treated with sunitinib.
    Duchnowska R; Miciuk B; Bodnar L; Waśniewski L; Szczylik C
    J Oncol Pharm Pract; 2013 Jun; 19(2):186-9. PubMed ID: 23037634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension as a predictive factor of Sunitinib activity.
    Rixe O; Billemont B; Izzedine H
    Ann Oncol; 2007 Jun; 18(6):1117. PubMed ID: 17586751
    [No Abstract]   [Full Text] [Related]  

  • 13. [Successful Management by Immunoglobulin for Sunitinib-Induced Thrombocytopenia in a Patient with Advanced Metastatic Renal Cell Carcinoma].
    Okazaki S; Hori J; Watanabe M; Hashizume K; Kobayashi S; Azumi M; Kita M; Iwata T; Matsumoto S; Kakizaki H
    Hinyokika Kiyo; 2016 Feb; 62(2):73-6. PubMed ID: 27018409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activity of SU11248, a multitargeted inhibitor of vascular endothelial growth factor receptor and platelet-derived growth factor receptor, in patients with metastatic renal cell carcinoma.
    Motzer RJ; Michaelson MD; Redman BG; Hudes GR; Wilding G; Figlin RA; Ginsberg MS; Kim ST; Baum CM; DePrimo SE; Li JZ; Bello CL; Theuer CP; George DJ; Rini BI
    J Clin Oncol; 2006 Jan; 24(1):16-24. PubMed ID: 16330672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prolonged complete responses and near-complete responses to sunitinib in metastatic renal cell carcinoma.
    Heng DY; Rini BI; Garcia J; Wood L; Bukowski RM
    Clin Genitourin Cancer; 2007 Dec; 5(7):446-51. PubMed ID: 18272027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sunitinib-induced thrombotic microangiopathy.
    Noronha V; Punatar S; Joshi A; Desphande RV; Prabhash K
    J Cancer Res Ther; 2016; 12(1):6-11. PubMed ID: 27072203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gingival bleeding and jaw bone necrosis in patients with metastatic renal cell carcinoma receiving sunitinib: report of 2 cases with clinical implications.
    Nicolatou-Galitis O; Migkou M; Psyrri A; Bamias A; Pectasides D; Economopoulos T; Raber-Durlacher JE; Dimitriadis G; Dimopoulos MA
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Feb; 113(2):234-8. PubMed ID: 22669112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blue toe syndrome and sunitinib.
    Postema PG; Regeer MV; van der Valk PR; Stroes ES; Richel DJ
    Int J Clin Oncol; 2011 Oct; 16(5):574-6. PubMed ID: 21136131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Food and Drug Administration drug approval summary: Sunitinib malate for the treatment of gastrointestinal stromal tumor and advanced renal cell carcinoma.
    Rock EP; Goodman V; Jiang JX; Mahjoob K; Verbois SL; Morse D; Dagher R; Justice R; Pazdur R
    Oncologist; 2007 Jan; 12(1):107-13. PubMed ID: 17227905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolerability of first-line therapy for metastatic renal cell carcinoma.
    Porta C; Szczylik C
    Cancer Treat Rev; 2009 May; 35(3):297-307. PubMed ID: 19249157
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.